Delivery Order SPE2DB22D3501-SPE2DB25FXE75
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials under firm fixed price terms. The contract is non-competitive and was executed on August 8, 2025, with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against the company's larger...
- The Defense Logistics Agency awarded a $6,389.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trodelvy 180 mg vials, with a completion deadline of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship with the federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $9,584.58 to supply Trodelvy 180 mg vials, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,584.58 for 180 mg vials of Trodelvy on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract represents a competitive, non-set-aside award and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a $9,584.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trodelvy 180 mg vials, with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency has awarded a delivery order valued at $23,961.45 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials. This firm fixed-price, non-set-aside contract was awarded on August 28, 2025, with an ultimate completion date of September 19, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trodelvy 180 mg vials, a specialty pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $9,584.58 and is scheduled for completion by October 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,987.15 for 180 mg vials of Trodelvy, a pharmaceutical product used in cancer treatment. The award, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with firm fixed-price pricing terms. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Trodelvy 180mg vials. This firm fixed-price delivery order, valued at $9,584.58, represents a non-competitive set-aside procurement and is scheduled for completion by July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular focus...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXE75Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,389.72 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials. This firm fixed price delivery order, issued on September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader SPE2DX prime vendor contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Trodelvy, a specialized oncology pharmaceutical, exemplifies the company's role in fulfilling critical medical supply needs across the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/5/25 |